ScanTech AI receives Nasdaq delisting notice; trading suspended Feb 10

ScanTech AI Systems Inc.

On Feb 4, 2026, Nasdaq notified ScanTech AI of MVPHS deficiency ($15M minimum) with 180-day cure period.
On Feb 6, 2026, Nasdaq Hearing Panel denied continued listing citing violations of Listing Rules 5250(c)(1) and 5450(b)(2)(A).
Trading of STAI common stock on Nasdaq Global Market suspended at open on Feb 10, 2026.
Company has 15 days to appeal to Nasdaq Listing and Hearing Review Council; intends to do so.
Company plans to apply for quotation on OTCQB Venture Market, but approval not assured.

item 3.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.